Chen Feng
Changzhou, 213003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Mechanistic insights into cordycepin-enhanced CTLA-4 blockade efficacy via Eubacterium rectale-mediated immunomodulation in colon cancer.
Journal: International immunopharmacology
Published: December 29, 2025
Development and application of a simple LC-MS/MS method for therapeutic drug monitoring to guide colistin dosing in critically Ill patients.
Journal: BMC pharmacology & toxicology
Published: December 15, 2025
Comparison of the effects of rapamycin and AZD8055 on colon cancer cells through UPLC-MS/MS-based metabolomics.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 03, 2025
LC-MS/MS quantification of omadacycline in human plasma for therapeutic drug monitoring: method development and clinical application.
Journal: Scientific reports
Published: June 13, 2025
Revisiting the Association Between Beta-blockers and Psoriasis: Evidence from Real-World Data.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: February 24, 2025
Cordycepin enhances the Anticancer efficacy of PD-L1 blockade by modulating the tumor microenvironment of colon cancer.
Journal: European journal of pharmacology
Published: July 18, 2024
Single-cell RNA sequencing indicates cordycepin remodels the tumor immune microenvironment to enhance TIGIT blockade's anti-tumor effect in colon cancer.
Journal: International immunopharmacology
Published: September 09, 2023
Cordycepin remodels the tumor microenvironment of colorectal cancer by down-regulating the expression of PD-L1.
Journal: Journal of cancer research and clinical oncology
Published: September 01, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026